Search Results - "Chuba, Paul J"

Refine Results
  1. 1

    Bilateral Risk for Subsequent Breast Cancer After Lobular Carcinoma-In-Situ: Analysis of Surveillance, Epidemiology, and End Results Data by CHUBA, Paul J, HAMRE, Merlin R, YAP, Johnny, SEVERSON, Richard K, LUCAS, David, SHAMSA, Falah, AREF, Amr

    Published in Journal of clinical oncology (20-08-2005)
    “…Noninvasive lesions involving the lobules of the breast are increasingly diagnosed as incidental microscopic findings at the time of lumpectomy or core-needle…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Sarcoma as a second malignancy after treatment for breast cancer by Yap, Johnny, Chuba, Paul J, Thomas, Ron, Aref, Amr, Lucas, David, Severson, Richard K, Hamre, Merlin

    “…Second malignant neoplasms may be a consequence of radiotherapy for the treatment of breast cancer. Prior studies evaluating sarcomas as second malignant…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Rare tumors: Retinoblastoma, nasopharyngeal cancer, and adrenocorticoid tumors by Patel, Samir, Vogel, Jennifer, Bradley, Kristin, Chuba, Paul J., Buchsbaum, Jeffrey, Krasin, Matthew J.

    Published in Pediatric blood & cancer (01-05-2021)
    “…The role of surgery, chemotherapy, and radiation therapy for retinoblastoma has evolved considerably over the years with the efficacy of intraarterial…”
    Get full text
    Journal Article
  6. 6

    Radiation and depression associated with complications of tissue expander reconstruction by Chuba, Paul J., Stefani, William A., Dul, Carrie, Szpunar, Susan, Falk, Jeffrey, Wagner, Rachael, Edhayan, Elango, Rabbani, Anna, Browne, Cynthia H., Aref, Amr

    Published in Breast cancer research and treatment (01-08-2017)
    “…Purpose Rates of implant failure, wound healing delay, and infection are higher in patients having radiation therapy (RT) after tissue expander (TE) and…”
    Get full text
    Journal Article
  7. 7

    Comparison of Three Groups of Patients Having Low Dose Rate Prostate Brachytherapy: Prostate-Specific Antigen Failure and Overall Survival by Booher, Jacquelyn, Domenig, Peter, Goldman, Benjamin, Campbell, Todd, Verdecchia, Kyle, Boura, Judith A, Chuba, Paul J

    Published in Curēus (Palo Alto, CA) (22-09-2021)
    “…Purpose To examine dosimetric and clinical outcomes for Cs-131 radioactive seed implant compared to Pd-103 and I-125.  Background/Significance Cs-131 is a…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The 1989 patterns of care study for prostate cancer: five-year outcomes by Chuba, P J, Moughan, J, Forman, J D, Owen, J, Hanks, G

    “…Five-year results from the 1989 patterns of care study (PCS) for prostate cancer are now ready for analysis. The PCS was initiated to determine national…”
    Get more information
    Journal Article
  10. 10

    A population-based study of racial and ethnic differences in survival among women with invasive cervical cancer: Analysis of Surveillance, Epidemiology, and End Results data by Patel, Divya A., Barnholtz-Sloan, Jill S., Patel, Mehul K., Malone, John M., Chuba, Paul J., Schwartz, Kendra

    Published in Gynecologic oncology (01-05-2005)
    “…The incidence of cervical cancer is higher in Hispanic than in non-Hispanic or African American women in the United States, but few studies have examined…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Three-dimensional visualization and dosimetry of stranded source migration following prostate seed implant by Daniel, Sarah, Rabbani, Cyrus, Aref, Amr, Taylor, Roy, Patel, Divya, Chuba, Paul J.

    Published in Practical Radiation Oncology (01-07-2012)
    “…Computed tomographic (CT) imaging was used to determine the displacement of stranded seeds between day 0 and day 30 following prostate seed implants. Post-plan…”
    Get full text
    Journal Article
  13. 13

    Hyperbaric oxygen therapy for radiation‐induced brain injury in children by Chuba, Paul J., Aronin, Patricia, Bhambhani, Kanta, Eichenhorn, Michael, Zamarano, Lucia, Cianci, Paul, Muhlbauer, Michael, Porter, Arthur T., Fontanesi, James

    Published in Cancer (15-11-1997)
    “…BACKGROUND Radiation‐induced necrosis (RIN) of the brain is a complication associated with the use of aggressive focal treatments such as radioactive implants…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Isotope selection and PSA failure in prostate seed implant: Experience with CS-131 in a community hospital system by Booher, Jacquelyn G., Domenig, Peter, Chuba, Paul J.

    Published in Journal of clinical oncology (20-02-2020)
    “…Abstract only 375 Background: A recent large single institutional study reported excellent long-term biochemical control and survival for Cs-131 prostate…”
    Get full text
    Journal Article
  17. 17

    Patterns of care and survival outcomes for young women treated for early breast cancers in a community hospital system by Thet, Aye, Hadid, Tarik H., Boura, Judith, Gohel, Narendra, Falk, Jeffrey, Vlachaki, Maria T., Jay, Allison, Chuba, Paul J.

    Published in Journal of clinical oncology (01-06-2022)
    “…e12586 Background: Younger women with breast cancer have relatively poor prognosis and higher rates of locoregional recurrence. Epidemiologic data suggest…”
    Get full text
    Journal Article
  18. 18

    Are there inequities in reconstruction after mastectomy in breast cancer patients related to race or insurance status? by Chuba, Paul J., Vlachaki, Maria T., Koerner, Sean, Stefani, William, Falk, Jeffrey

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only e12615 Background: Patients with invasive or in-situ breast cancers may increasingly be offered bilateral mastectomy with reconstruction with a…”
    Get full text
    Journal Article
  19. 19

    Adding precision to 2018 ASCO/CAP HER2 testing guidelines in breast cancer with genomic profiling by Brufsky, Adam, Crozier, Jennifer A., Chuba, Paul J., Lee, Sung Ho, Menicucci, Andrea, Kling, Heather M., Yoder, Erin, Audeh, William

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 3570 Background: Biological heterogeneity of HER2 positive breast cancers has been suggested by a modest benefit of HER2-targeted therapies…”
    Get full text
    Journal Article
  20. 20